Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins - PubMed (original) (raw)
. 1992 Jul 25;267(21):14998-5004.
Affiliations
- PMID: 1378843
Free article
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins
M Neeper et al. J Biol Chem. 1992.
Free article
Abstract
Advanced glycosylation end products of proteins (AGEs) are nonenzymatically glycosylated proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes. A approximately 35-kDa polypeptide with a unique NH2-terminal sequence has been isolated from bovine lung and found to be present on the surface of endothelial cells where it mediates the binding of AGEs (receptor for advanced glycosylation end product or RAGE). Using an oligonucleotide probe based on the amino-terminal sequence of RAGE, an apparently full-length cDNA of 1.5 kilobases was isolated from a bovine lung cDNA library. This cDNA encoded a 394 amino acid mature protein comprised of the following putative domains: an extracellular domain of 332 amino acids, a single hydrophobic membrane spanning domain of 19 amino acids, and a carboxyl-terminal domain of 43 amino acids. A partial clone encoding the human counterpart of RAGE, isolated from a human lung library, was found to be approximately 90% homologous to the bovine molecule. Based on computer analysis of the amino acid sequence of RAGE and comparison with databases, RAGE is a new member of the immunoglobulin superfamily of cell surface molecules and shares significant homology with MUC 18, NCAM, and the cytoplasmic domain of CD20. Expression of the RAGE cDNA in 293 cells allowed them to bind 125I-AGE-albumin in a saturable and dose-dependent manner (Kd approximately 100 nM), blocked by antibody to RAGE. Western blots of 293 cells transfected with RAGE cDNA probed with anti-RAGE IgG demonstrated expression of immunoreactive protein compared to its absence in mock-transfected cells. These results suggest that RAGE functions as a cell surface receptor for AGEs, which could potentially mediate cellular effects of this class of glycosylated proteins.
Similar articles
- Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.
Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M, et al. Schmidt AM, et al. J Biol Chem. 1992 Jul 25;267(21):14987-97. J Biol Chem. 1992. PMID: 1321822 - Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.
Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, Stern D. Schmidt AM, et al. J Clin Invest. 1993 May;91(5):2155-68. doi: 10.1172/JCI116442. J Clin Invest. 1993. PMID: 8387541 Free PMC article. - The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide.
Schmidt AM, Mora R, Cao R, Yan SD, Brett J, Ramakrishnan R, Tsang TC, Simionescu M, Stern D. Schmidt AM, et al. J Biol Chem. 1994 Apr 1;269(13):9882-8. J Biol Chem. 1994. PMID: 8144581 - The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
Hori O, Yan SD, Ogawa S, Kuwabara K, Matsumoto M, Stern D, Schmidt AM. Hori O, et al. Nephrol Dial Transplant. 1996;11 Suppl 5:13-6. doi: 10.1093/ndt/11.supp5.13. Nephrol Dial Transplant. 1996. PMID: 9044300 Review. - Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
Schmidt AM, Yan SD, Wautier JL, Stern D. Schmidt AM, et al. Circ Res. 1999 Mar 19;84(5):489-97. doi: 10.1161/01.res.84.5.489. Circ Res. 1999. PMID: 10082470 Review.
Cited by
- Association between endothelial function and skin advanced glycation end-products (AGEs) accumulation in a sample of predominantly young and healthy adults.
Fewkes JJ, Dordevic AL, Murray M, Williamson G, Kellow NJ. Fewkes JJ, et al. Cardiovasc Diabetol. 2024 Sep 9;23(1):332. doi: 10.1186/s12933-024-02428-3. Cardiovasc Diabetol. 2024. PMID: 39251982 Free PMC article. - Subcutaneous advanced glycation end products, cardiovascular risk factors and vascular health during childhood development in a Swiss population.
Hauser C, Lona G, Köchli S, Streese L, Infanger D, Faude O, Hanssen H. Hauser C, et al. Front Physiol. 2024 Jul 19;15:1371618. doi: 10.3389/fphys.2024.1371618. eCollection 2024. Front Physiol. 2024. PMID: 39100277 Free PMC article. - Glycation resistance and life-history traits: lessons from non-conventional animal models.
Duval C, Criscuolo F, Bertile F. Duval C, et al. Biol Lett. 2024 Jun;20(6):20230601. doi: 10.1098/rsbl.2023.0601. Epub 2024 Jun 12. Biol Lett. 2024. PMID: 38863347 Free PMC article. Review. - Bioinformatics identification and validation of maternal blood biomarkers and immune cell infiltration in preeclampsia: An observational study.
Wang H, Li H, Rong Y, He H, Wang Y, Cui Y, Qi L, Xiao C, Xu H, Han W. Wang H, et al. Medicine (Baltimore). 2024 May 24;103(21):e38260. doi: 10.1097/MD.0000000000038260. Medicine (Baltimore). 2024. PMID: 38788026 Free PMC article. - Erjingwan and Alzheimer's disease: research based on network pharmacology and experimental confirmation.
Xu Y, Zhang J, Li X. Xu Y, et al. Front Pharmacol. 2024 Apr 29;15:1328334. doi: 10.3389/fphar.2024.1328334. eCollection 2024. Front Pharmacol. 2024. PMID: 38741585 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous